Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients-Reference-Cited by-同舟云学术

Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients

Published:2018-02 Issue:6 Volume:71 Page:636-650
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Asleh Rabea,Briasoulis Alexandros,Kremers Walter K.,Adigun Rosalyn,Boilson Barry A.,Pereira Naveen L.,Edwards Brooks S.,Clavell Alfredo L.,Schirger John A.,Rodeheffer Richard J.,Frantz Robert P.,Joyce Lyle D.,Maltais Simon,Stulak John M.,Daly Richard C.,Tilford Jonella,Choi Woong-Gil,Lerman Amir,Kushwaha Sudhir S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report—2015; focus theme: early graft failure;Lund;J Heart Lung Transplant,2015

2. Allograft vasculopathy versus atherosclerosis;Rahmani;Circ Res,2006

3. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation;Tuzcu;J Am Coll Cardiol,2005

4. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years;Kobashigawa;J Am Coll Cardiol,2005

5. Effect of pravastatin on outcomes after cardiac transplantation;Kobashigawa;N Engl J Med,1995

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States;The Journal of Heart and Lung Transplantation;2024-10

2. Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

3. Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial;The Journal of Heart and Lung Transplantation;2024-08

4. A Case of Successful Treatment of Severe Hyperlipidemia After Heart Transplantation With Inclisiran;Kardiologiia;2024-07-31

5. The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects;Kardiologiia;2024-07-31